Seminars in Nuclear Medicine
Volume 39, Issue 6 , Pages 357-368, November 2009

Advantages and Limitations of Imaging the Musculoskeletal System by Conventional Radiological, Radionuclide, and Hybrid Modalities

  • Sanjay Vijayanathan, MRCP, FRCR

      Affiliations

    • Department of Radiology, Guys and St Thomas' NHS Foundation Trust, London, United Kingdom
    • Corresponding Author InformationAddress reprint requests to Sanjay Vijayanathan, Department of Radiology, Guys and St Thomas' NHS Foundation Trust, Lambeth Palace Rd, London SE1 7EH, United Kingdom
  • ,
  • Sajid Butt, MBBS, FRCR

      Affiliations

    • Royal National Orthopaedic Hospital, Stanmore, Middlesex, United Kingdom
  • ,
  • Gopinath Gnanasegaran, MD

      Affiliations

    • Department of Radiology, Guys and St Thomas' NHS Foundation Trust, London, United Kingdom
  • ,
  • Ashley M. Groves, MD

      Affiliations

    • Institute of Nuclear Medicine, UCL, London, United Kingdom

The endpoint of an efficient and accurate diagnosis of musculoskeletal pathology can take many different routes. Currently, conventional radiological techniques, such as plain radiography, ultrasonography, computed tomography, and magnetic resonance imaging are used in the assessment of patients with benign and malignant bone disease. An understanding of the advantages and limitations of the modalities available will help expedite diagnosis, and hence treatment. In this review, we discuss the advantages and limitations of the modalities available in investigating benign and malignant musculoskeletal pathology.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(09)00046-4

doi:10.1053/j.semnuclmed.2009.07.001

Seminars in Nuclear Medicine
Volume 39, Issue 6 , Pages 357-368, November 2009